Genentech: James Mulligan | Senior Machine Learning Scientist, AI for Drug Discovery (Structure, Scoring, and Simulation), Prescient Design

Scientists / Our Scientists

I joined Genentech in 2025, following my time at Calico Life Sciences where I worked on machine learning models for molecular design. Previous to that, I completed a PhD and postdoc in physics where I focused on computational and machine learning methods to model subatomic particles.

My current research focuses on developing machine learning and physics-based methods to design new molecular therapeutics.

Yale University, PhD in Physics – 2018
University of Washington, BS in Physics, Math – 2012

Attention: This page may not render properly. The browser you are using, Internet Explorer 10, is no longer supported.

James Mulligan

Senior Machine Learning Scientist, AI for Drug Discovery (Structure, Scoring, and Simulation), Prescient Design